HPGC RENMINTONGTAI PHARMACEUTICAL CORPORATION

HPGC Renmintongtai Pharmaceutical Corporation

600829

CNE000000G05

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 22/05/2024 BST			5-day change	1st Jan Change
6.54 ^CNY	-2.39%		-4.25%	-16.37%

04-19	HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-27	HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI

HPGC Renmintongtai Pharmaceutical Corporation announced that it has received funding from Harbin Pharmaceutical Group Co., Ltd.

December 08, 2019

On December 9, 2019, HPGC Renmintongtai Pharmaceutical Corporation (SHSE:600829) closed the transaction.

Latest news about HPGC Renmintongtai Pharmaceutical Corporation

HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	04-19	CI
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	03-27	CI
HPGC Renmintongtai Chairman Steps Down; Successor Named	12-18	MT
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Nine Months Ended September 30, 2023	24/10/23	CI
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Half Year Ended June 30, 2023	11/08/23	CI
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	20/04/23	CI
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Nine Months Ended September 30, 2022	24/10/22	CI
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Half Year Ended June 30, 2022	12/08/22	CI
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	20/04/22	CI
HPGC Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	25/03/22	CI
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Nine Months Ended September 30, 2021	15/10/21	CI
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Half Year Ended June 30, 2021	06/08/21	CI
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021	19/04/21	CI
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2020	19/03/21	CI
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Nine Months Ended September 30, 2020	16/10/20	CI
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Half Year Ended June 30, 2020	14/08/20	CI
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2020	17/04/20	CI
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2019	10/04/20	CI
HPGC Renmintongtai Pharmaceutical Corporation Approves Amending of Articles of Association	11/12/19	CI
HPGC Renmintongtai Pharmaceutical Corporation announced that it has received funding from Harbin Pharmaceutical Group Co., Ltd.	08/12/19	CI
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Nine Months Ended September 30, 2019	18/10/19	CI
Harbin Pharmaceutical Group Holding Co., Ltd. made an offer to acquire minority stake in HPGC Renmintongtai Pharmaceutical Corporation for CNY 0.02 million.	24/09/19	CI
Harbin Pharmaceutical Group Holding Co., Ltd. made an offer to acquire 25.2% stake in HPGC Renmintongtai Pharmaceutical Corporation for approximately CNY 970 million.	22/08/19	CI
Hpgc Renmintongtai Pharmaceutical Corporation Reports Earnings Results for the Half Year Ended June 30, 2019	16/08/19	CI
HPGC Renmintongtai Pharmaceutical Corporation announced that it expects to receive funding from Harbin Pharmaceutical Group Co., Ltd.	29/04/19	CI

Chart HPGC Renmintongtai Pharmaceutical Corporation

Duration

Period

Chart HPGC Renmintongtai Pharmaceutical Corporation

More charts

HPGC Renmintongtai Pharmaceutical Corporation, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co., Ltd., is a China-based company, principally engaged in the wholesale and retail of pharmaceuticals. The Company principally engages in the sales of Chinese medicines and western drugs. It also engages in the sales of medical equipment, healthcare products, daily necessities, glass apparatus, chemical, among others. The Company distributes its products mainly within domestic markets.

Sector

Pharmaceuticals

Calendar

06/06/2024 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
HPGC RENMINTONGTAI PHARMACEUTICAL CORPORATION	-16.37%	537M
MCKESSON CORPORATION	+20.53%	72.45B
CARDINAL HEALTH, INC.	-4.71%	23.46B
SINOPHARM GROUP CO. LTD.	+4.89%	8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+7.11%	8.35B
HUADONG MEDICINE CO., LTD	-23.73%	7.88B
H. LUNDBECK A/S	+13.92%	5.21B
EBOS GROUP LIMITED	-0.59%	4.11B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+7.85%	4.09B
CHINA NATIONAL MEDICINES CORPORATION LTD.	+20.65%	3.6B